You may be eligible if you are:

  • A resident of the United States
  • A pregnant woman who has:
    • Been diagnosed with uterine fibroids or endometriosis; or
    • Taken MYFEMBREE® during pregnancy or just prior to pregnancy (within 13 days prior to conception)

Contact request form

Complete this form and a registry team member will contact you with more information about participating in the Registry.

* marks required field.

I authorize the MyRose Pregnancy Registry to contact me and/or leave a message for me at these numbers or to contact me via email at the address listed below. I agree to the Registry referencing the MyRose Pregnancy Registry in messages or emails.

Please identify the best time of day for contact. The registry is open from 8:30 AM - 5:00 PM ET.

Privacy Statement:

Pharmaceutical Product Development, LLC. (PPD) respects your privacy and understands that it is important to you. The information you provide on this form will be used to contact you for the purposes of assessing your eligibility to participate in the MyRose Pregnancy Registry. This information will be held by PPD and not shared with the study sponsor (Sumitomo Pharma Switzerland GmbH) or any other third party without your permission. In the event you choose not to enroll, Registry staff will request permission to share your contact information with Sumitomo Pharma Switzerland GmbH in order for them to contact you for safety follow up about your pregnancy. If you do not provide permission, and do not enroll in the Registry your contact details will be deleted.

Additional Information